As we learn more about precision medicine and how to identify biomarkers, Peter Tun, Manager, Magnolia Innovation, would like to see more discussion among stakeholders on how to optimize these findings in future gatherings.
Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.
Subscribe